Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Blood|April 25, 2024
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissionsSasanka M Handunnetti, Mary Ann Anderson, Kate Burbury, et al.
The New England Journal of Medicine|December 8, 2015
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic LeukemiaAndrew W Roberts, Matthew S Davids, John M Pagel, et al.
Cancer Discovery|December 6, 2018
Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic LeukemiaPiers Blombery, Mary Ann Anderson, Jia-Nan Gong, et al.
Blood|June 16, 2022
Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapyRachel Thijssen, Luyi Tian, Mary Ann Anderson, et al.
Cell Death and Differentiation|April 9, 2025
Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteinsJia-Nan Gong, Tirta M Djajawi, Donia M Moujalled, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin LymphomaMatthew S Davids, Andrew W Roberts, John F Seymour, et al.
The Lancet. Oncology|January 17, 2017
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b studyJohn F Seymour, Shuo Ma, Danielle M Brander, et al.
Internal Medicine Journal|July 7, 2026
Australasian chronic lymphocytic leukaemia consensus statement: 2026 updateSean McKeague, Joanna Katarzyna Czerwinski, Xavier Badoux, et al.
Blood|October 29, 2024
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemiaMeng-Xiao Luo, Tania Tan, Marie Trussart, et al.
The Journal of Infectious Diseases|July 2, 2025
Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination TrialVictoria G Hall, Thi H O Nguyen, Olivia C Smibert, et al.
Pageof 10